-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q2 2025.
- Vir Biotechnology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 138M shares, a 1.63% increase year-over-year.
- Vir Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 136M shares, a 1.58% increase from 2023.
- Vir Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 134M shares, a 0.5% decline from 2022.
- Vir Biotechnology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 135M shares, a 1.03% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)